AR and neoplasm: Single-cell segmentation analyses revealed that whereas metastatic lesions contain fewer activated-ARhigh cells (~ 20–40% of the tumor cell population) compared with primary tumors (~ 50–90%), those fewer metastatic cells nonetheless exhibited higher levels of activated AR than primary tumor cells (Fig. 6b).